Increased beneficial outcome of metformin by co-enzyme Q10 against experimentally-induced hind limb ischemia reperfusion injury in normal and diabetic rats


  • Eman A. Abdel-Aziz Department of Pharmacology, Faculty of Medicine, Benha University, Egypt
  • Heba A. Elnoury Department of Pharmacology, Faculty of Medicine, Benha University, Egypt



Co-enzyme q10, Ischemia reperfusion, Metformin, Rats


Background: Skeletal muscles are susceptible for ischemic reperfusion injury especially in settings in order to achieve homeostasis in traumatic injury and vascular surgery. This study aimed at investigating the implication of induction of diabetes on generation of ischemic reperfusion injury in rat gastrocnemius muscle. In addition, the possible beneficial effect of metformin and co-enzyme q10 was investigated.

Methods: About 80 male adult Sprague Dawley rats divided into 10 groups. Metformin was administrated as continuous oral dose for 28 days. Coenzyme q10 was administrated parenterally 2 and 24 hours before induction of ischemia in diabetic and non-diabetic animals.

Results: In diabetic ischemic groups, tested drugs either singly or in combination significantly reduce HB1cA and plasma levels of muscle specific enzyme CPK and muscle myokin IL6, raised natural antioxidant GSH and reduced oxidative stress parameters (SOD and MDA), apoptotic (caspase-3) and inflammatory parameters TNF-α and TGFβ were reduced. Continuous oral metformin for 28 days was more powerful than parenteral short-term coenzyme q10 as regards all tested parameters except for GSH and caspase-3 both drugs were equi-effective. Combined drugs have more powerful ameliorating effect than either drug singly except for HB1cA which was equi-effective with that of metformin. Regarding non diabetic ischemic groups, metformin was more powerful in reduction of caspase-3, IL6 and TNF- α while coenzyme q10 was more powerful in elevating GSH.

Conclusions: Co-enzyme q10 can be used as add on therapy with metformin in order to decrease the deleterious effects resulted from hind limb ischemia reperfusion in normal and diabetic rats.


Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000;190(3):255-66.

Holcomb JB, McMullin NR, Pearse L, Caruso J, Wade CE, Oetjen-Gerdes L, et al. Causes of death in US Special Operations Forces in the global war on terrorism: 2001-2004. Ann Surg. 2007;245(6):986.

Lutchmansingh FK, Hsu JW, Bennett FI, Badaloo AV, McFarlane-Anderson N, Gordon-Strachan GM, et al. Glutathione metabolism in type 2 diabetes and its relationship with microvascular complications and glycemia. PloS One. 2018;13(6):e0198626.

Viollet B, Guigas B, Garcia NS, Leclerc J, Foretz M, Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clin Sci. 2012;122(6):253-70.

Pajet GE, Barnes JM. Evaluation of drug activities. Pharmacometrics. New York; Academic Press: 1964;1:161.

Prem JT, Eppinger M, Lemmon G, Miller S, Nolan D, Peoples J. The role of glutamine in skeletal muscle ischemia/reperfusion injury in the rat hind limb model. Am J Surg. 1999;178(2):147-50.

Kakadiya J, Patel D, Shah N. Effect of hesperidin on renal complication in experimentally induced renal damage in diabetic sprague dawley rats. J Ecobiotechnol. 2010;2:45-50.

Miles MV. The uptake and distribution of coenzyme Q (10). Mitochondrion. 2007;7:S72-7.

Parasuraman S, Raveendran R, Kesavan R. Blood sample collection in small laboratory animals. J Pharmacol Pharmacotherapeutics. 2010;1(2):87.

Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochem. 1976;72(1-2):248-54.

Nolan Y, Maher FO, Martin DS, Clarke RM, Brady MT, Bolton AE, et al. Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus. J Biol Chem. 2005;280(10):9354-62.

Sun YI, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34(3):497-500.

Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990;186:407-21.

Browne RW, Armstrong D. Reduced glutathione and glutathione disulfide. Free Radical and Antioxidant Protocols. Humana Press. 1998:347-52.

Abdel-Wahab AF, Al-Harizy WM. Propofol protects against ischemia/reperfusion injury associated with reduced apoptosis in rat liver. ISRN Anesthesiol. 2013:517478.

Jeukendrup AE. Regulation of fat metabolism in skeletal muscle. Ann New York Academy Sci. 2002;967(1):217-35.

Conner EM, Grisham MB. Inflammation, free radicals, and antioxidants. Nutrition. 1996;12(4):274-7.

Cutrín JC, Zingaro B, Camandola S, Boveris A, Pompella A, Poli G. Contribution of γ glutamyl transpeptidase to oxidative damage of ischemic rat kidney. Kidney Int. 2000;57(2):526-33.

Hunt JV, Dean RT, Wolff SP. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J. 1988;256(1):205-12.

Wang Z, Gleichmann H. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diab. 1998;47(1):50-6.

Manna R, Migliore A, Martin LS, Ferrara E, Ponte E, Marietti G, et al. Nicotinamide treatment in subjects at high risk of developing IDDM improves insulin secretion. Brit J Clin Prac. 1992;46(3):177-9.

Kolb H, Burkart V. Nicotinamide in type 1 diabetes. Diab Care. 1999;22:B16.

Wolff SP, Dean RT. Glucose autoxidation and protein modification. The potential role of autoxidative glycosylation in diabetes. Biochem J. 1987;245:243-50.

Fu MX, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. The advanced glycation end product, N-(carboxymethyl) lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem. 1996;271(17):9982-6.

Dong R,Wang Q, He XL, Chu YK, Lu JG. Role of nuclear factor kappa B and reactive oxygen species in the tumor necrosis factor-induced epithelial-mesenchymal transition of MCF-7 cells. Braz J Med Biol Res. 2007;40:1071-8.

Islam IH. Ameliorative effect of apelin on streptozotocin-induced diabetes and its associated cardiac hypertrophy. Alexandria J Med. 2018;54:119-27.

Francés DE, Ronco MT, Monti JA, Ingaramo PI, Pisani GB, Parody JP, et al. Hyperglycemia induces apoptosis in rat liver through the increase of hydroxyl radical: new insights into the insulin effect. J Endocrinol. 2010;205(2):187.

Guz G, Oz E, Lortlar N, UlusuN N, Nurlu N, Demirogullari B, et al. The effect of taurine on renal ischemia reperfusion injury. Amino Acids. 2007;32: 405-11.

Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol. 1998;106:1659-65.

Karina BG, Kathryna FR, Ana PF. The role of transforming growth factor-beta in diabetic nephropathy. Int J Med Genetics.2014;180270:1-6.

Aruna DP, JoAnn EM, Nader R. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327-34.

Kristiansen OP, Poulsen TP. Interleukin-6 and diabetes. The Good, the Bad, or the Indifferent? Diab. 2007;54:S114-S124.

Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diab. 2015;6:456-80.

Seiji M, Kiyohiko D, Kazuo Y, Takashi K. Changes in the levels of endogenous coenzyme Q homologs, α-tocopherol and glutathione in rat liver after hepatic ischemia and reperfusion, and the effect of pretreatment with coenzyme Q10. Biochim Biophysic (BBA)-General Subjects. 1984;797:1-9.

Groneberg DA, Kindermann B, Althammer M, Klapper M, Vormann J, Littarru GP, Doring F. Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells. Int J Biochem Cell Biol. 2005;37:1208-18.

Gholami M, Khayat ZK, Anbari K, et al. Quercetin ameliorates peripheral nerve ischemia-reperfusion injury through the NF-kappa B pathway. Anat Sci Int. 2017;92(3):330-7.

Fouad AA, Al-Sultan AI, Refaie SM, Yacoubi MT. Coenzyme Q10 treatment ameliorates acute cisplatin nephrotoxicity in mice. Env Toxicol Pharmacol. 2010;274:49-56.

Qu H, Guo M, Chai H, Wang WT, Gao ZY, Shi DZ. Effects of coenzyme Q10 on statin‐induced myopathy: an updated meta‐analysis of randomized controlled trials. J Am Heart Assoc. 2018;7:009835.

Vilela DD, Peixoto LG, Teixeira RR, Baptista NB, Caixeta DC, Souza AV, et al. The role of metformin in controlling oxidative stress in muscle of diabetic rats. Oxidative Med Cell Longevity. 2016;6978625:1-9.

Oliveira WH, Nunes AK, Françaetal MR. Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice. Brain Res. 2016;1644:149-60.




How to Cite

Abdel-Aziz, E. A., & Elnoury, H. A. (2019). Increased beneficial outcome of metformin by co-enzyme Q10 against experimentally-induced hind limb ischemia reperfusion injury in normal and diabetic rats. International Journal of Basic & Clinical Pharmacology, 8(5), 987–994.



Original Research Articles